Several data have shown the existence of a positive relationship between circulating DPP4 activity and the presence and severity of a number of chronic hepatic disorders, ranging from hepatitis C virus (HCV)-related hepatitis [137] and cirrhosis [138] to NASH [139] and NAFLD [140,141]. Here, DPP4 is linked to metabolic dysfunction-associated steatotic liver disease.